DOVDover Corporation
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $2.88Beat
- vs $2.83 expected on Oct 22
- Stock move on it
- −2.18%
- one session
- Typical move
- ±5.0%
- average over 2 reports
- Price
- $209.46
- −1.40% today · $26.7B cap
Past and upcoming reports
2
| Oct 22, 2026 | Sep 30, 2026 | Time not given | $2.83 | Beat$2.88 | −2.18% |
| Jul 23, 2026 | Jun 30, 2026 | Time not given | $2.72 | Missed$2.44 | −7.80% |
After the report
Jul 23, 2026 report
This covers the Jul 23, 2026 report. The Oct 22, 2026 numbers are in the table above.
Dover EPS Misses by 10.3%. Stock Rises 2.2% on Day 2 as Market Looks Past Print to Guidance and Valuation Support
Dover reported Q2 2026 EPS of $2.44, a 10.3% miss vs. the $2.72 consensus, marking a negative surprise. Despite the miss, the stock rose 2.2% on the second day after the print, closing at $202.20. The market appears to be pricing in a forward-looking view, supported by a strong balance sheet (D/E 0.44), a 33% discount to sector on forward P/E (19.4x vs 28.7x), and a buy-tilted analyst consensus (10 buy, 2 hold) with a $251.08 target. The post-earnings narrative likely focused on the miss being transitory and reaffirmed guidance, though no specific guidance data is available in the payload. The key tension is between a weak EPS growth trajectory (-51.7% TTM) and a valuation that already prices in a recovery.
Reported against expected
MissedEPS of $2.44 missed the $2.72 consensus estimate by -10.3% ($0.28), a clear miss.
Guidance
No specific guidance data is available in the payload. The stock's positive reaction suggests the market interpreted management's tone as reassuring, but this cannot be confirmed with provided data.
How the stock reacted
The stock closed at $202.20 on July 24, up 2.2% from the previous close of $197.80, despite the EPS miss. The day's range was $200.00-$204.79, with volume of 2.04M shares.
What changed
EPS missed consensus by 10.3%, but stock rose 2.2%, signaling the miss was already discounted.
What the price now assumes
The market is pricing a recovery thesis, supported by a 33% forward P/E discount to sector.
What it means for the business
Upgrade bias with caution. watch next quarter's EPS for confirmation of the growth trajectory.
The next one to three months, as we saw it then
Better case35%
The EPS miss was a one-off, and the market correctly looks past it. Strong balance sheet (D/E 0.44) and +9.5% next-year EPS growth drive re-rating toward the $251 analyst target.
Base case45%
The miss is a temporary setback, but growth remains intact. The stock trades in a range between $190 and $215, supported by valuation but capped by uncertainty about the pace of recovery.
Worse case20%
The EPS miss signals a fundamental deterioration. TTM EPS growth of -51.7% is not a one-off, and the stock's positive reaction is a dead-cat bounce. Valuation (PEG 2.08) is still pricing in too much growth.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.